Market Place
Sourcing Support
Viriom and Chromis publish results of a multi-center open label post-marketing
10 Mar 2021 //
PRNEWSWIRE
Viriom, Chromis’ Avifavir reduces time to virus elimination in Covid-19 patients
09 Mar 2021 //
PHARMACEUTICAL-TECHNOLOGY
Elpida (elsulfavirine) becomes the preferred first line therapy for treatment
02 Feb 2021 //
PRNEWSWIRE
Viriom initiates ph2 study of intramuscular injectable nanoformulation VM1500A
05 May 2020 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.